Biocon likely to seek full marketing authorisation for Covid-19 drug
Bangalore-headquartered Biocon may consider applying for full marketing authorisation for itolizumab, a novel antibody product used to treat
Read moreBangalore-headquartered Biocon may consider applying for full marketing authorisation for itolizumab, a novel antibody product used to treat
Read morePress Trust of IndiaJul 28, 2020 11:42:57 IST New Delhi: Five sites across the country are ready for the third
Read more